Moneycontrol
HomeNewsHealth & FitnessBlack fungus | Patients have right to life, can't be given preference over others: Delhi HC
Trending Topics

Black fungus | Patients have right to life, can't be given preference over others: Delhi HC

The court said it was sure that a patient's granddaughter, who was seeking direction to the government and Sir Ganga Ram Hospital to provide sufficient number of vials of Amphotericin B to him, was not seeking any preferential treatment over other patients.

May 27, 2021 / 19:42 IST
Story continues below Advertisement

A graphic representation of the black fungus affecting COVID-19 patients (Image: News18 Creative)

The Delhi High Court Thursday said every patient has a right to life and to live with dignity but it cannot give privilege to anyone over other patients for providing medicine to treat black fungus, primarily affecting those recovered or recovering from COVID-19.

The court said it was sure that a patient's granddaughter, who was seeking direction to the government and Sir Ganga Ram Hospital to provide sufficient number of vials of Amphotericin B to him, was not seeking any preferential treatment over other patients.

Story continues below Advertisement

Black Fungus Infection | India cannot allow another bug to dictate terms to us

Since the petitioner has now been included in the system set up in place for allocation of medicine for treatment of black fungus, we are hopeful that further allocation will be made while making it for other patients at Sir Ganga Ram Hospital as well, a bench of Justices Vipin Sanghi and Jasmeet Singh said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show